Evidence map›Paper›PMID 10947953›Full record

ArticleThe Biochemical journal2000

A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.

S Ohta, M Takeuchi, M Deguchi, T Tsuji, Y Gahara, K Nagata

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Insulin Infusion Is Linked to IncreasedJournal of the Endocrine Society · 2021
    Article
  2. Article
  3. Article
  4. Serine/Threonine Protein Kinase STK16.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S OhtaShionogi Research Laboratories, Shionogi & Co. Ltd, 5-12-4Sagisu, Fukushima-ku, Osaka, Osaka 553-0002, Japan.
M Takeuchi
M Deguchi
T Tsuji
Y Gahara
K Nagata
Shionogi (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-beta) shows a variety of biological activities in various organs or cells. Recently some factors such as Smads (Sma and Mad proteins) and TGF-beta activating kinase 1 ('TAK1') have been characterized as signalling molecules downstream of TGF-beta. Several TGF-beta response elements have been identified such as cAMP response element, Smad binding element, and recognition sites for activating protein-1 and stimulating protein-1 in various gene promoters. We also reported a TGF-beta response element in the human C-type natriuretic peptide (CNP) gene promoter. In this paper, we report on a novel factor which regulates the TGF-beta response promoter. This factor, named TSF1 (TGF-beta stimulated factor 1), possessed DNA-binding ability and activated the TGF-beta responsive CNP promoter or vascular endothelial growth factor gene promoter which possesses a sequence element analogous to the TGF-beta responsive GC-rich element of the CNP promoter. TSF1 did not directly activate a Smads-dependent promoter from plasminogen activator inhibitor 1 gene, but it showed enhancement in co-operation with Smad3 and Smad4. Interestingly, this factor had the structural features of a Ser/Thr kinase and actually exhibited protein kinase activity. TSF1 mRNA as well as its protein level were stimulated by TGF-beta treatment. Thus, TSF1 is an unique factor with two biological functions, transcriptional regulation and protein phosphorylation, that may be involved in TGF-beta signals.

Indexed as

Amino Acid SequenceAnimalsBlotting, NorthernBlotting, WesternCell LineCloning, MolecularDNADNA-Binding ProteinsDNA, ComplementaryDose-Response Relationship, DrugEndothelial Growth FactorsEnzyme ActivationEscherichia coliGene Expression RegulationHeLa CellsHumansDNADNA-Binding ProteinsDNA, ComplementaryEndothelial Growth FactorsLymphokinesPhosphotransferasesPlasminogen Activator Inhibitor 1Protein Serine-Threonine KinasesRecombinant ProteinsSmad3 ProteinSMAD3 protein, humanSmad3 protein, mouseSmad3 protein, ratSmad4 ProteinSMAD4 protein, humanSmad4 protein, mouseSmad4 protein, ratSTK16 protein, humanStk16 protein, mouseStk16 protein, ratTrans-ActivatorsTranscription FactorsTransforming Growth Factor betaVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID10947953
PMCPMC1221266
OpenAlexW2160522456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.